{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:16:58Z","timestamp":1788945418104,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["125010011"],"award-info":[{"award-number":["125010011"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicaltuberculosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jctube.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T19:16:18Z","timestamp":1489864578000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands"],"prefix":"10.1016","volume":"7","author":[{"given":"Gerard","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"van Hest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Erkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"van den Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieneke","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Oud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Slump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"van Dissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9979","key":"10.1016\/j.jctube.2017.02.002_bib0001","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"72","author":"Kochi","year":"1991","journal-title":"Tubercle."},{"issue":"2","key":"10.1016\/j.jctube.2017.02.002_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3329\/jhpn.v28i2.4879","article-title":"Tuberculosis: A Global Health Problem","volume":"28","author":"Zaman","year":"2010","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.jctube.2017.02.002_bib0004","unstructured":"Framework towards tuberculosis elimination in low-incidence countries, Geneva: World Health Organization; 2014. Report No.: WHO\/HTM\/TB\/2014.13."},{"issue":"4","key":"10.1016\/j.jctube.2017.02.002_bib0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jctube.2017.02.002_bib0006","unstructured":"Tuberculose in Nederland 2015 - Surveillance rapport inclusief rapportage monitoring van interventies. Bilthoven: RIVM; 2016."},{"key":"10.1016\/j.jctube.2017.02.002_bib0007","series-title":"Global tuberculosis control","year":"2016"},{"key":"10.1016\/j.jctube.2017.02.002_bib0008","unstructured":"Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2014. Report No.: WHO\/HTM\/TB\/2015.01."},{"issue":"6","key":"10.1016\/j.jctube.2017.02.002_bib0009","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J."},{"issue":"5","key":"10.1016\/j.jctube.2017.02.002_bib0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1183\/13993003.00449-2016","article-title":"Advancing global programmatic management of latent tuberculosis infection for at risk populations","volume":"47","author":"Getahun","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jctube.2017.02.002_bib0011","unstructured":"Report of the Global Consultation on the Programmatic Management of Latent Tuberculosis Infection, 27-28 April 2016, Seoul, Republic of Korea [Internet]. Geneva: World Health Organization; 2016. Report No.: WHO\/HTM\/TB\/2016.08. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/246106\/1\/WHO-HTM-TB-2016.08-eng.pdf"},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0012","first-page":"1","article-title":"The Netherlands: health system review","volume":"12","author":"Sch\u00e4fer","year":"2010","journal-title":"Health Syst Transit."},{"key":"10.1016\/j.jctube.2017.02.002_bib0013","doi-asserted-by":"crossref","unstructured":"World Economic Outlook Database-April 2016, International Monetary Fund. http:\/\/www.imf.org\/external\/data.htm. 2016.","DOI":"10.5089\/9781513519333.081"},{"key":"10.1016\/j.jctube.2017.02.002_bib0014","unstructured":"GDP per capita (current US$), World Bank. http:\/\/databank.worldbank.org\/data\/reports.aspx?source=2&series=NY.GDP.PCAP.CD&country=. 2016."},{"key":"10.1016\/j.jctube.2017.02.002_bib0015","series-title":"The White Plague: Tuberculosis, Man, and Society","author":"Dubos","year":"1952"},{"key":"10.1016\/j.jctube.2017.02.002_bib0016","unstructured":"Droeze H. Jr., J.J. De sterfte aan phthisis in Nederland: academisch proefschrift ter verkrijging van den graad van Doctor in de Geneeskunde aan de Rijksuniversiteit te Leiden. 1879."},{"key":"10.1016\/j.jctube.2017.02.002_bib0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3201\/eid1104.041103","article-title":"Tuberculosis elimination in the Netherlands","volume":"11","author":"Borgdorff","year":"2005","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.jctube.2017.02.002_bib0018","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1183\/09031936.00155409","article-title":"Progress towards tuberculosis elimination: secular trend, immigration and transmission","volume":"36","author":"Borgdorff","year":"2010","journal-title":"Eur Respir J."},{"issue":"2","key":"10.1016\/j.jctube.2017.02.002_bib0019","first-page":"3","article-title":"\u201cKnow your epidemic\u201d: de tbc-situatie in Nederland","volume":"110","author":"de Vries","year":"2014","journal-title":"Tegen Tuberc"},{"key":"10.1016\/j.jctube.2017.02.002_bib0020","unstructured":"National Tuberculosis Control Plan 2011-2015. Bilthoven: RIVM; 2010."},{"key":"10.1016\/j.jctube.2017.02.002_bib0021","unstructured":"National Tuberculosis Control Plan 2016-2020. Towards Elimination [Internet]. Bilthoven: RIVM; 2016. Available from: http:\/\/www.rivm.nl\/en\/Documents_and_publications\/Scientific\/Reports\/2016\/maart\/National_Tuberculosis_Control_Plan_2016_2020_Towards_elimination."},{"key":"10.1016\/j.jctube.2017.02.002_bib0022","unstructured":"Tuberculosis action plan for the WHO European Region 2016\u20132020. Denmark: World Health Organization Regional Office for Europe; 2015."},{"key":"10.1016\/j.jctube.2017.02.002_bib0023","unstructured":"Handboek Tuberculose 2016. Den Haag: KNCV Tuberculosefonds; 2016."},{"key":"10.1016\/j.jctube.2017.02.002_bib0024","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ. 1982;60(4):555\u201364."},{"key":"10.1016\/j.jctube.2017.02.002_bib0025","doi-asserted-by":"crossref","unstructured":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council. Am Rev Respir Dis. 1992 Jan;145(1):36\u201341.","DOI":"10.1164\/ajrccm\/145.1.36"},{"issue":"2","key":"10.1016\/j.jctube.2017.02.002_bib0026","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jctube.2017.02.002_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007545.pub2","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","author":"Sharma","year":"2013","journal-title":"Cochrane Database Syst Rev Online."},{"key":"10.1016\/j.jctube.2017.02.002_bib0028","doi-asserted-by":"crossref","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jctube.2017.02.002_bib0029","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.arbres.2013.07.009","article-title":"Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology","volume":"50","author":"Solsona Peir\u00f3","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jctube.2017.02.002_bib0030","unstructured":"CPT-leidraad voor beleid bij fibrotische afwijkingen die bij radiologische screening worden vastgesteld. Den Haag Commissie voor Praktische Tuberculosebestrijding, KNCV Tuberculosefonds; 2014."},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0031","first-page":"27","article-title":"Electronic reporting improves timeliness and completeness of infectious disease notification. The Netherlands","volume":"10","author":"Ward","year":"2005","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"issue":"5","key":"10.1016\/j.jctube.2017.02.002_bib0032","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1183\/13993003.01397-2015","article-title":"Monitoring latent tuberculosis infection diagnosis and management in the Netherlands","volume":"47","author":"Erkens","year":"2016","journal-title":"Eur Respir J."},{"issue":"5","key":"10.1016\/j.jctube.2017.02.002_bib0033","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01157-2016","article-title":"Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands","volume":"48","author":"Erkens","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jctube.2017.02.002_bib0034","unstructured":"Evaluatie bron- en contactonderzoek bij tuberculosepati\u00ebnten in Nederland, 2006-2010. Den Haag: KNCV Tuberculosefonds; 2014."},{"key":"10.1016\/j.jctube.2017.02.002_bib0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0962-8479(92)90058-R","article-title":"Microepidemics of tuberculosis: the stone-in-the-pond principle","volume":"73","author":"Veen","year":"1992","journal-title":"Tuber Lung Dis"},{"issue":"6","key":"10.1016\/j.jctube.2017.02.002_bib0036","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J."},{"issue":"7","key":"10.1016\/j.jctube.2017.02.002_bib0037","first-page":"820","article-title":"Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis","volume":"13","author":"Kik","year":"2009","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.jctube.2017.02.002_bib0038","series-title":"Tuberculosis Transmission in the Netherlands","author":"Kik","year":"2009"},{"issue":"2","key":"10.1016\/j.jctube.2017.02.002_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/eurpub\/ckr017","article-title":"Missed opportunities in tuberculosis control in The Netherlands due to prioritization of contact investigations","volume":"22","author":"Mulder","year":"2012","journal-title":"Eur J Public Health."},{"issue":"6","key":"10.1016\/j.jctube.2017.02.002_bib0040","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1183\/09031936.00010612","article-title":"Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection","volume":"40","author":"Mulder","year":"2012","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.jctube.2017.02.002_bib0041","doi-asserted-by":"crossref","first-page":"e60130","DOI":"10.1371\/journal.pone.0060130","article-title":"Predictive value of the tuberculin skin test among newly arriving immigrants","volume":"8","author":"Mulder","year":"2013","journal-title":"PloS One."},{"key":"10.1016\/j.jctube.2017.02.002_bib0042","series-title":"Tuberculosis control among immigrants","author":"Mulder","year":"2013"},{"issue":"10","key":"10.1016\/j.jctube.2017.02.002_bib0043","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.5588\/ijtld.15.0975","article-title":"European shortage of purified protein derivative and its impact on tuberculosis screening practices","volume":"20","author":"Tebruegge","year":"2016","journal-title":"Int J Tuberc Lung Dis."},{"issue":"3","key":"10.1016\/j.jctube.2017.02.002_bib0044","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1183\/13993003.01464-2015","article-title":"Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection","volume":"47","author":"Hoff","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jctube.2017.02.002_bib0045","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jctube.2017.02.002_bib0046","unstructured":"https:\/\/e-detecttb.eu\/ [Internet]. Available from: https:\/\/e-detecttb.eu\/"},{"issue":"34","key":"10.1016\/j.jctube.2017.02.002_bib0047","article-title":"Identifying components for programmatic latent tuberculosis infection control in the European Union","volume":"21","author":"Sandgren","year":"2016","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0048","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","author":"Oxlade","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.jctube.2017.02.002_bib0049","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","article-title":"Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis","volume":"11","author":"Pareek","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.jctube.2017.02.002_bib0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-015-1045-3","article-title":"A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries","author":"Zammarchi","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jctube.2017.02.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056044","article-title":"How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI","author":"Oxlade","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0052","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1183\/13993003.00575-2016","article-title":"Preventing and controlling tuberculosis among refugees in Europe: more needed for high-risk populations","volume":"48","author":"de Vries","year":"2016","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.jctube.2017.02.002_bib0053","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1183\/13993003.00329-2016","article-title":"Preventing and controlling tuberculosis among refugees in Europe: more is needed","volume":"48","author":"Dara","year":"2016","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.jctube.2017.02.002_bib0054","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1183\/13993003.00840-2016","article-title":"Tuberculosis care among refugees arriving in Europe: a ERS\/WHO Europe Region survey of current practices","volume":"48","author":"Dara","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.jctube.2017.02.002_bib0055","series-title":"Stichting HIV Monitoring","year":"2016"},{"key":"10.1016\/j.jctube.2017.02.002_bib0056","unstructured":"CPT-richtlijn Tuberculose-HIV. Den Haag: Commissie voor Praktische Tuberculosebestrijding, KNCV Tuberculosefonds; 2016."}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240557941630033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240557941630033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T22:54:58Z","timestamp":1568933698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240557941630033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":56,"alternative-id":["S240557941630033X"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2017.02.002","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}